ESR
2.7.1.7. Clear ethical rules of interaction between pharmaceutical companies and healthcare professionals have been defined, which make it impossible to abuse the prescription of medicines to patients; legal liability for violations of these rules has been established
Problem solving:
2.7.1. Patients and doctors do not receive medications and medical devices in a timely manner and in full, in particular due to the incomplete transition to the new system of organization and control of medical procurement, and the incomplete regulation of the processes of identifying the needs for and accounting of medications
Deadlines for all measures within ESR
Implementation of SACP measures within ESR
Implementation of SACP measures within the scope of the Problem by main main performers
Ministry of Health of Ukraine
Summarized general information on Measures
Indicators of achievement of ESR
Total number of indicators – 1
Indicators fully achieved – 0
Partially achieved indicators – 0
Indicators with a score of 0% – 1
Summarized general information about Achievement Indicators
№ | Indicators | Weight (%) |
---|---|---|
1 |
The law on amendments to the Fundamentals of Ukrainian Healthcare Legislation has taken effect, which defines: a) the list of prohibited forms of interaction of medical workers and healthcare institutions with business entities that manufacture and/or distribute medications and medical devices (medical products) and auxiliary means of rehabilitation and with their representatives (in particular: medical workers and healthcare institutions are prohibited from accepting samples of medications, medical devices, souvenirs, and branded products of pharmaceutical companies for purposes of promotion; pharmaceutical companies are prohibited from launching loyalty programs for doctors) (50 percent); b) the ethical principles to be upheld by medical workers when prescribing medications and medical devices to patients (20 percent); c) disciplinary and administrative liability (under Article 442 of the Code of Ukraine on Administrative Offenses) for violations of restrictions applicable to the forms of interaction of medical workers with business entities manufacturing and/or distributing medications, medical devices (medical products), and auxiliary means of rehabilitation (30 percent). |
100% |